Run-Long Medtech Files IPO Prospectus: Targeting Integrated Solutions in China's Rapidly Growing Sports Medicine Market with 24.3% CAGR

When it comes to sports medicine, many people’s immediate reaction is that it is a specialized medical field tailored for athletes—professional healthcare services needed only by famous athletes like Yao Ming, Liu Xiang, and Lang Ping after they suffer sports-related injuries.

In fact, with the improvement of living standards and fitness awareness among Chinese residents, the number of people participating in sports has increased significantly, leading to a rise in sports-related injuries. According to data from the State Council’s National Fitness Plan (2016–2020) and the Outline of the “Healthy China 2030” Initiative, along with key indicators for building a Healthy China, the number of people in China who regularly participated in physical exercise reached 360 million in 2015, is projected to reach 435 million by 2020, and 530 million by 2030. Currently, the incidence rate of sports injuries in China is approximately 10–20%. Based on these figures, the number of individuals suffering from sports injuries will reach 100 million by then, indicating substantial demand for industries related to sports medicine.

Sports medicine is an interdisciplinary and comprehensive science that integrates medicine with sports. It investigates the physiological and pathological effects of physical activity and sedentary behavior on the human body, as well as the prevention, treatment, and functional rehabilitation of sports-related injuries and disorders. Its ultimate goals are to enhance the physical fitness of the general population, safeguard the health of individuals engaged in sports, and improve athletic performance. Although sports medicine currently represents the smallest subspecialty within orthopedics, it is experiencing the most rapid growth in both global and domestic markets.

According to data from Global Market Insights, the global sports medicine market size will exceed $9 billion in 2025, with an average annual growth rate of nearly 8%, significantly higher than that of traditional orthopedics (2–3%) and orthopedic consumables (5%). In China, the growth rate of sports medicine is even more rapid.

Wang Zhongran, the founder of Run-Long Medtech, was once a key driver in the development of sports medicine in China. Since 1998, when he served as Senior Sales Director for Sports Medicine at Smith & Nephew, a global leader in the field, he began actively promoting and cultivating China’s sports medicine sector. Under his influence, the market grew from nearly zero to a multi-billion-yuan industry, at one point achieving a 70% market share. During his 17-year tenure at Smith & Nephew, Mr. Wang placed the greatest emphasis on physician education, aiming to train more doctors and continuously improve surgical techniques, thereby driving the ongoing advancement of the industry.

While witnessing and driving the growth of sports medicine in China, Mr. Wang Zhongran is driven by a strong sense of mission to harness local strength in the field. He aims to provide high-quality, domestically produced products to physicians across China, securing a significant foothold for Chinese enterprises in a market dominated by foreign companies through superior quality and service. If Mr. Wang was a pioneer 20 years ago, today he aspires to lead Run-Long Medtech as a dedicated cultivator.

Run-Long Medtech boasts an exceptional management team. Mr. Tang Wei, the General Manager, has fifteen years of experience in the medical industry. He is driven by his passion for the orthopedics sector, his confidence in jointly building a domestic independent brand, and his enthusiasm for collaborating with the founder and the team to cultivate the field of sports medicine.

As a company dedicated to sports medicine, Run-Long Medtech has focused on this field for the past three years, initiating the R&D and registration of its full product portfolio. Currently, Run-Long Medtech’s sterile orthopedic shaver burrs and titanium alloy suture anchors have received approval for sale. Notably, Run-Long Medtech is the only domestic manufacturer capable of providing shaver burrs compatible with four mainstream interfaces as well as one proprietary interface, driving rapid growth in market sales.

Tang Wei shared that since 2017, Run-Long Medtech has focused its primary efforts on shaver systems. Among consumables used in sports medicine, shavers account for 25% of the consumable cost per surgical procedure. While some procedures may not require implants, every procedure necessitates the use of shavers and radiofrequency (RF) ablation probes. Furthermore, during product research and development and manufacturing, Run-Long Medtech discovered that the industrial supply chain foundation for domestically produced medical devices in China is relatively weak.

It is no easy feat to meticulously craft premium-quality products. For instance, while many types of steel used in infrastructure construction have achieved domestic production in China, domestically produced steels for medical device manufacturing often fail to meet required standards. Moving forward, Run-Long Medtech will focus its efforts on radiofrequency system consumables and the shoulder joint sector.

Tang Wei stated, “Medical device companies fall into two categories: one comprises large platform-based enterprises that achieve expansion through continuous mergers and acquisitions; the other consists of product-focused companies that drive growth through specific product innovations. At this stage, Run-Long Medtech remains a young player in the sports medicine sector, and we are dedicated to refining individual products with meticulous attention to detail.” He also believes that a significant driving force behind the development of sports medicine in China is the increasing number of orthopedic surgeons specializing in sports medicine, as more orthopedic physicians are turning their attention to this field. Market training and education for physicians provided by companies are of paramount importance.

Domestic sports medicine in China is still in its nascent stage. The medical device industry is a challenging sector, yet it offers sustainable growth prospects. We are confident that the core management team of Run-Long Medtech—leveraging years of clinical experience in orthopedics at Grade A tertiary hospitals, expertise in the design and development of orthopedic implants and sports medicine products, thorough familiarity with R&D processes, product standards, and regulatory registration requirements, as well as extensive frontline experience in market expansion for orthopedic medical devices—will grow alongside China’s sports medicine industry. The future of domestic sports medicine holds great promise.